Literature DB >> 6860617

Steroid responsiveness in connective tissue diseases.

H Gaston, M J Absolon, O A Thurtle, M A Sattar.   

Abstract

Thirty-four patients with connective tissue disease used dexamethasone drops 0.1% in one eye for 6 weeks. There was a higher incidence of positive steroid response than would be expected in a normal population. Most of the male patients were responders. Care should be exercised when prescribing local steroids for these patients. Males should be offered regular screening for glaucoma.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6860617      PMCID: PMC1040100          DOI: 10.1136/bjo.67.7.487

Source DB:  PubMed          Journal:  Br J Ophthalmol        ISSN: 0007-1161            Impact factor:   4.638


  8 in total

1.  EFFECT OF CORTICOSTEROIDS ON INTRAOCULAR PRESSURE AND FLUID DYNAMICS. I. THE EFFECT OF DEXAMETHASONE IN THE NORMAL EYE.

Authors:  M F ARMALY
Journal:  Arch Ophthalmol       Date:  1963-10

2.  TOPICAL CORTICOSTEROIDS AND HEREDITY IN PRIMARY OPEN-ANGLE GLAUCOMA.

Authors:  B BECKER; K A HAHN
Journal:  Am J Ophthalmol       Date:  1964-04       Impact factor: 5.258

3.  INTRAOCULAR PRESSURE RESPONSE TO TOPICAL CORTICOSTEROIDS.

Authors:  B BECKER
Journal:  Invest Ophthalmol       Date:  1965-04

4.  STATISTICAL ATTRIBUTES OF THE STEROID HYPERTENSIVE RESPONSE IN THE CLINICALLY NORMAL EYE. I. THE DEMONSTRATION OF THREE LEVELS OF RESPONSE.

Authors:  M F ARMALY
Journal:  Invest Ophthalmol       Date:  1965-04

5.  Incidence of eye disease in cases of connective tissue disease.

Authors:  J Williamson
Journal:  Trans Ophthalmol Soc U K       Date:  1974-09

6.  Ankylosing spondylitis and rheumatoid arthritis.

Authors:  E C Huskisson; F D Hart
Journal:  Proc R Soc Med       Date:  1970-06

7.  Corticosteroid provocative tests.

Authors:  T Akingbehin
Journal:  Trans Ophthalmol Soc U K       Date:  1982-07

8.  The coexistence of rheumatoid arthritis with Reiter's syndrome and/or ankylosing spondylitis: a model of dual HLA-associated disease susceptibility and expression.

Authors:  E L Alexander; W B Bias; F C Arnett
Journal:  J Rheumatol       Date:  1981 May-Jun       Impact factor: 4.666

  8 in total
  10 in total

Review 1.  Locally administered ocular corticosteroids: benefits and risks.

Authors:  Charles N J McGhee; Simon Dean; Helen Danesh-Meyer
Journal:  Drug Saf       Date:  2002       Impact factor: 5.606

Review 2.  Corticosteroids and glaucoma risk.

Authors:  R C Tripathi; S K Parapuram; B J Tripathi; Y Zhong; K V Chalam
Journal:  Drugs Aging       Date:  1999-12       Impact factor: 3.923

Review 3.  Ocular side effects of anti-rheumatic medications: what a rheumatologist should know.

Authors:  V Peponis; V C Kyttaris; S E Chalkiadakis; S Bonovas; N M Sitaras
Journal:  Lupus       Date:  2010-02-09       Impact factor: 2.911

4.  Corticosteroids and open-angle glaucoma in the elderly: a population-based cohort study.

Authors:  Michael W Marcus; Rogier P H M Müskens; Wishal D Ramdas; Roger C W Wolfs; Paulus T V M De Jong; Johannes R Vingerling; Albert Hofman; Bruno H C Stricker; Nomdo M Jansonius
Journal:  Drugs Aging       Date:  2012-12       Impact factor: 3.923

Review 5.  Corticosteroids in ophthalmology: drug delivery innovations, pharmacology, clinical applications, and future perspectives.

Authors:  Sherif A Gaballa; Uday B Kompella; Omar Elgarhy; Ali M Alqahtani; Barbara Pierscionek; Raid G Alany; Hamdy Abdelkader
Journal:  Drug Deliv Transl Res       Date:  2021-06       Impact factor: 4.617

6.  Glaucoma associated with the management of rhegmatogenous retinal detachment.

Authors:  George Mangouritsas; Spyridon Mourtzoukos; Dimitra M Portaliou; Vassilios I Georgopoulos; Anastasia Dimopoulou; Elias Feretis
Journal:  Clin Ophthalmol       Date:  2013-04-15

Review 7.  Steroid-induced Glaucoma: An Avoidable Irreversible Blindness.

Authors:  Sonia Phulke; Sushmita Kaushik; Savleen Kaur; S S Pandav
Journal:  J Curr Glaucoma Pract       Date:  2017-08-05

Review 8.  Clinical utility of intravitreal fluocinolone acetonide (Iluvien®) implant in the management of patients with chronic diabetic macular edema: a review of the current literature.

Authors:  Habiba Saedon; Astha Anand; Yit C Yang
Journal:  Clin Ophthalmol       Date:  2017-03-27

9.  Axial Length as a Risk Factor for Steroid-Induced Ocular Hypertension.

Authors:  Wungrak Choi; Jung Dong Kim; Hyoung Won Bae; Chan Yun Kim; Gong Je Seong; Min Kim
Journal:  Yonsei Med J       Date:  2022-09       Impact factor: 3.052

10.  Effects of intrapolyp steroid injection on intraocular pressure and recurrent polyp treatment.

Authors:  Tae-Hoon Lee; Jung-Gwon Nam; Chang Kyu Lee
Journal:  Eye (Lond)       Date:  2021-09-16       Impact factor: 4.456

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.